TRU-SENTIMENT · DeltaNeutral
XBI Trading Analysis - 11/20/2026 04:18 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
XBI (State Street SPDR S&P Biotech ETF) at $140.55. True Sentiment Bearish, delta 40-60 call 6% / put 94%, call $339,580 vs put $5,258,655. RSI 35.9.
- Symbol
- XBI
- Price
- $140.55
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-11-20 16:18:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow sentiment: Bearish. Call dollar volume $339,580.00 (6.1%) vs put dollar volume $5,258,655.00 (93.9%). Total $5,598,235.00. Put contracts 8,099 vs call 527. Pure directional conviction heavily favors puts.
Near-term expectation: strong bearish positioning into 2026-12-18. Divergence: technicals also bearish, so no divergence — sentiment confirms weak price action.
Call Volume: $339,580.00 (6.1%) Put Volume: $5,258,655.00 (93.9%) Total: $5,598,235.00
Key Statistics: XBI
Fundamental Snapshot
Valuation
| Market cap | $9.84B |
| Shares outstanding | 70.0M |
Dividend
| Dividend yield | 0.38% |
| Annual dividend | $0.54 |
| Ex-dividend date | 2026-06-22 |
Risk & range
| Beta | 1.01 |
| 52-week low | $113.57 |
| 52-week high | $169.89 |
| Historical volatility | 39.2% |
Ownership & trading
| Institutional ownership | 7.7% |
| Average daily volume | 8.7M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
The following recent context items are based on general knowledge and are separated from the data-driven analysis below:
- Biotech sector ETFs like XBI have faced pressure amid ongoing FDA regulatory uncertainty and slower IPO activity in late 2026.
- Recent broad market rotation out of small-cap and speculative biotech names has weighed on XBI demand.
- No specific XBI earnings catalyst exists as it is an ETF, but underlying clinical trial results from major holdings have shown mixed outcomes.
- Macro rate-cut expectations have faded, reducing appetite for high-beta biotechnology exposures.
- Headlines suggest defensive positioning, which aligns with the heavily bearish options flow and weak technicals in the embedded data.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for XBI:
- Revenue growth (YoY and recent trends): Not available (totalRevenue and revenueGrowth are null).
- Profit margins (gross, operating, net): Not available (profitMargins is null).
- Earnings per share (EPS): Not available (trailingEps and forwardEps are null).
- P/E ratio and valuation: trailingPE and forwardPE are null; pegRatio is null. No valuation multiples can be computed from data.
- Key concerns: institutionalPercent is only 7.71%, indicating low institutional ownership; priceToBook, debtToEquity, returnOnEquity, freeCashflow all null.
- Market cap is $9,838,500,000.00 with 70,000,000.00 shares outstanding; dividend yield 0.38% (rate $0.54).
- 52-week range: low $113.57, high $169.89; beta 1.01; historical volatility 39.24%.
- Analyst consensus and target: recommendationKey and targetMeanPrice are null — no analyst context in data.
- Fundamentals show limited fundamental透明度 (many nulls) and low institutional hold; this diverges from technical weakness but offers no bullish offset.
Current Market Position
Current price per indicators is $144.47 (as of 2026-11-19 close). Minute bars show 2026-11-20 15:50:00 close at $140.55, down from 2026-11-19 09:30 open of $145.38. Recent daily history: 2026-11-16 close $145.66, 2026-11-19 close $144.47, with 30-day low $143.24 (2026-11-17) and high $160.29 (2026-10-29).
Intraday momentum: First 5 minute bars on 2026-11-19 opened $145.38 and drifted to $145.31 by 09:50; last 5 minute bars on 2026-11-20 show slide from $140.74 to $140.55 on rising volume (446,012 at 15:50). Weak intraday trend.
Technical Analysis
Technical Indicators
SMA alignment: SMA 5 ($146.22) < SMA 20 ($152.18) < SMA 50 ($153.08) — bearish stack, no bullish crossovers. RSI 35.86 shows bearish momentum near oversold but not extreme. MACD negative with histogram -0.41 confirms downside momentum. Bollinger Bands: middle $152.18, upper $161.04, lower $143.33; price below lower band suggests extended. 30-day range: high $160.29, low $143.24; current $144.47 sits near bottom 8% of range.
True Sentiment Analysis (Delta 40-60 Options)
Options flow sentiment: Bearish. Call dollar volume $339,580.00 (6.1%) vs put dollar volume $5,258,655.00 (93.9%). Total $5,598,235.00. Put contracts 8,099 vs call 527. Pure directional conviction heavily favors puts.
Near-term expectation: strong bearish positioning into 2026-12-18. Divergence: technicals also bearish, so no divergence — sentiment confirms weak price action.
Call Volume: $339,580.00 (6.1%) Put Volume: $5,258,655.00 (93.9%) Total: $5,598,235.00
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.